PainReform Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Ilan Hadar

Chief executive officer

US$563.0k

Total compensation

CEO salary percentage51.0%
CEO tenure3.5yrs
CEO ownershipn/a
Management average tenure4.8yrs
Board average tenure4yrs

Recent management updates

Recent updates

We're Keeping An Eye On PainReform's (NASDAQ:PRFX) Cash Burn Rate

Jul 03
We're Keeping An Eye On PainReform's (NASDAQ:PRFX) Cash Burn Rate

PainReform reports results

Aug 16

We're Hopeful That PainReform (NASDAQ:PRFX) Will Use Its Cash Wisely

Sep 19
We're Hopeful That PainReform (NASDAQ:PRFX) Will Use Its Cash Wisely

Companies Like PainReform (NASDAQ:PRFX) Are In A Position To Invest In Growth

May 23
Companies Like PainReform (NASDAQ:PRFX) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Ilan Hadar's remuneration changed compared to PainReform's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$563kUS$287k

-US$9m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022US$1mUS$321k

-US$9m

Compensation vs Market: Ilan's total compensation ($USD563.00K) is about average for companies of similar size in the US market ($USD664.85K).

Compensation vs Earnings: Ilan's compensation has been consistent with company performance over the past year.


CEO

Ilan Hadar (54 yo)

3.5yrs

Tenure

US$563,000

Compensation

Mr. Ilan Hadar, MBA, serves as Director at Silexion Therapeutics Ltd. Since June 2023. Mr. Hadar served as Chief Financial Officer & Treasure at Menlo Therapeutics Inc. since March 9, 2020.He is Chief Exe...


Leadership Team

NamePositionTenureCompensationOwnership
Ehud Geller
Executive Chairman15.5yrsUS$276.00k0%
$ 0
Ilan Hadar
CEO & CFO3.5yrsUS$563.00kno data
Sigal Aviel
Chief Operating Officer10.3yrsUS$351.00kno data
Eli Hazum
CTO & Director6.1yrsUS$270.00kno data
Rita Keynan
Vice President of Pharmaceutical Operations3.3yrsUS$353.00kno data
Stephen Cooper
Executive Vice President of Developmentno datano datano data

4.8yrs

Average Tenure

54yo

Average Age

Experienced Management: PRFX's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ehud Geller
Executive Chairman15.5yrsUS$276.00k0%
$ 0
Eli Hazum
CTO & Director4.4yrsUS$270.00kno data
Augustine Lawlor
Independent External Director3.7yrsno datano data
Ellen Baron
Independent External Director3.7yrsno datano data
Efraim Cohen-Arazi
Independent Directorno datano datano data

4.0yrs

Average Tenure

68yo

Average Age

Experienced Board: PRFX's board of directors are considered experienced (4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.